Secretary Robert F. Kennedy Jr. has opened a new chapter of federal vaccine policy that invites questions on issues long ...

Moderna on Monday said its experimental mRNA-based flu vaccine produced a stronger immune response than a currently available shot in a late-stage trial, clearing a path forward for the product and ...

New members of the ACIP began their tenure by shifting the posture of the 60-year-old panel from support for vaccine ...

mRNA-1010 demonstrated superior relative vaccine efficacy that was 26.6% (95% CI; 16.7%, 35.4%) higher than a licensed standard-dose seasonal influenza vaccine in adults aged 50 years and older ...

His 4-year-old son was at risk because he had received only the first of the vaccine’s two doses. So, in mid-March, he took his family to a primary care clinic at the University of Texas Medical ...

Holidaymakers have been alerted to a disruption in the supply of a crucial vaccine, which is expected to be 'unavailable' for the next 2-3 weeks. Sanofi has informed NaTHNaC that there will be a ...

The shot’s efficacy was 27% higher than a licensed influenza vaccine in adults 50 years and older, the company said in a statement Monday. The trial enrolled more than 40,000 adults across 11 ...

Nagpur: \"HPV vaccines are not only for girls. boys from 9 to 26 years of age should also take them. HPV isn't just about ...

Vaccine maker Moderna, Inc. (MRNA) said on Monday that its experimental seasonal flu vaccine demonstrated strong effectiveness in a late-stage study as compared to a currently available standard-dose ...

Prime Minister Narendra Modi's upcoming five-nation tour, beginning on July 2, will see significant advancements in India's bilateral relations with African nations of Ghana and Namibia, including the ...

ASTANA – Religious reasons were found to be relatively weakly linked to vaccine refusal in Kazakhstan. Public distrust in the ...

Dr. Elizabeth Hawse, a pediatrician in Lexington, says the thimerosal preservative was taken out of the flu vaccine close to ...